Krystal Biotech (KRYS) FCF Margin (2023 - 2026)

Krystal Biotech (KRYS) reported FCF Margin of 62.92% for Q1 2026, up 3483.0% on a YoY basis from 1.76% in Q1 2025, and down 10.23% sequentially from 70.08% in Q4 2025.

Krystal Biotech (KRYS) FCF Margin (2023 - 2026) Analysis & Trends

Krystal Biotech (KRYS) has 4 years of FCF Margin data on file, last reported at 62.92% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin rose 3483.0% year-over-year to 62.92%; the trailing twelve-month figure through Mar 2026 stood at 59.01% (up 2150.0% YoY), and the FY2025 full-year result was 50.83%, up 1127.0% from the prior year.
  • FCF Margin eased to 62.92% in Q1 2026, from 70.08% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 76.32% in Q3 2024 to a low of 153.14% in Q3 2023.
  • A 4-year average of 19.68% and a median of 41.27% in 2025 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin jumped 22946 bps in 2024 and slumped 3505 bps in 2025, its largest moves.
  • Tracing KRYS's FCF Margin over 4 years: stood at 37.46% in 2023, then soared by 240 bps to 52.43% in 2024, then surged by 34 bps to 70.08% in 2025, then slipped by 10 bps to 62.92% in 2026.
  • Business Quant data shows KRYS's FCF Margin at 62.92% in Q1 2026, 70.08% in Q4 2025, and 41.27% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 10.45%
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 23.53%
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Krystal Biotech 9.84 Bn 9.02 Bn 110.08 Mn 62.92%

Historic Data

Download Data
DateValue
Mar 31, 2026 62.92%
Dec 31, 2025 70.08%
Sep 30, 2025 41.27%
Jun 30, 2025 59.98%
Mar 31, 2025 28.08%
Dec 31, 2024 52.43%
Sep 30, 2024 76.32%
Jun 30, 2024 -16.32%
Mar 31, 2024 32.33%
Dec 31, 2023 -37.46%
Sep 30, 2023 -153.14%